Stocks
Gossamer Bio (GOSS) EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -209.4 | -211.1 | -161.9 | -40.0 | -162.3 | -170.0 | ||
| Changes by years, y/y, % | -10% | +1% | -23% | -75% | +306% | -7.1% | |||
Gossamer Bio. EBITDA US GAAP, bln rub
Gossamer Bio. EBITDA US GAAP, changes, %
Gossamer Bio. EBITDA US GAAP, sum by quarters, bln rub
Gossamer Bio (GOSS) EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -33.6 | -35.3 | -45.5 | -44.3 | -44.9 | -170.0 | |
| Changes by years, y/y, % | -11% | -161% | +62% | +40% | +34% | |||
| Changes by quarters, q/q, % | +6% | +5% | +29% | -2% | +1% | |||
